Sincalide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for sincalide and what is the scope of patent protection?

Sincalide is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sincalide has ten patent family members in eight countries.

There are three drug master file entries for sincalide. One supplier is listed for this compound.

Summary for sincalide

International Patents:	10
US Patents:	1
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	37
Clinical Trials:	4
Patent Applications:	4,568
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for sincalide
What excipients (inactive ingredients) are in sincalide?	sincalide excipients list
DailyMed Link:	sincalide at DailyMed

Recent Clinical Trials for sincalide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Bristol-Myers Squibb	Phase 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A
Penn State University	N/A

See all sincalide clinical trials

Pharmacology for sincalide

Drug Class	Cholecystokinin Analog

US Patents and Regulatory Information for sincalide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Free Forever Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bracco	KINEVAC	sincalide	INJECTABLE;INJECTION	017697-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Free Forever Trial	⤷ Free Forever Trial	Y			⤷ Free Forever Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for sincalide

Subscribe to access the full database, or Free Forever Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bracco	KINEVAC	sincalide	INJECTABLE;INJECTION	017697-001	Approved Prior to Jan 1, 1982	⤷ Free Forever Trial	⤷ Free Forever Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for sincalide

Subscribe to access the full database, or Free Forever Trial
Country	Patent Number	Estimated Expiration
China	1756557	⤷ Free Forever Trial
Australia	2003304382	⤷ Free Forever Trial
Japan	4751993	⤷ Free Forever Trial
Germany	60336509	⤷ Free Forever Trial
European Patent Office	1631305	⤷ Free Forever Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.